BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32347562)

  • 1. Dual-targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn's disease.
    Vernero M; Ribaldone DG; Cariti C; Ribero S; Susca S; Astegiano M; Dapavo P
    J Dermatol; 2020 Jun; 47(6):e216-e217. PubMed ID: 32347562
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab.
    Lipka S; Katz S; Ginzburg L
    J Crohns Colitis; 2013 Jun; 7(5):427-8. PubMed ID: 22926276
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
    Alkhouri N; Hupertz V; Mahajan L
    Inflamm Bowel Dis; 2009 Jun; 15(6):803-6. PubMed ID: 18942748
    [No Abstract]   [Full Text] [Related]  

  • 4. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
    Shaath TS; Om A; Wolfe CM; Cohen GF
    J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
    Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
    Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auricular pyoderma gangrenosum associated with Crohn's disease.
    Ben Chaabane N; Hellara O; Ben Mansour W; Ben Mansour I; Melki W; Loghmeri H; Safer L; Bdioui F; Saffar H
    Tunis Med; 2012 May; 90(5):414-5. PubMed ID: 22585655
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab.
    Grange F; Djilali-Bouzina F; Weiss AM; Polette A; Guillaume JC
    Dermatology; 2002; 205(3):278-80. PubMed ID: 12399677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
    Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease.
    Teich N
    Tech Coloproctol; 2014 Oct; 18(10):965-6. PubMed ID: 24965074
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory, disfiguring vulvar pyoderma gangrenosum and Crohn's disease.
    Borum ML; Cannava M; Myrie-Williams C
    Dig Dis Sci; 1998 Apr; 43(4):720-2. PubMed ID: 9558025
    [No Abstract]   [Full Text] [Related]  

  • 14. Henoch-schönlein purpura in an adult mimicking Crohn's disease and pyoderma gangrenosum.
    Samuel S; Loftus EV; Sandborn WJ
    Dig Dis Sci; 2011 Jul; 56(7):2205-6. PubMed ID: 21249449
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.
    Nunes G; Patita M; Fernandes V
    J Crohns Colitis; 2019 May; 13(6):812-813. PubMed ID: 30535292
    [No Abstract]   [Full Text] [Related]  

  • 16. Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.
    García Cámara P; Zubiri Ara ML; García López S
    Med Clin (Barc); 2019 Oct; 153(8):e35-e36. PubMed ID: 30795905
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of hidradenitis suppurativa and Crohn's disease with combined guselkumab and apremilast.
    Agud-Dios M; Arroyo-Andrés J; Rubio-Muñiz C; Postigo-Lorente C
    Dermatol Ther; 2022 Oct; 35(10):e15743. PubMed ID: 35904888
    [No Abstract]   [Full Text] [Related]  

  • 18. Education and Imaging. Gastrointestinal: pyoderma gangrenosum of the thumb.
    Sundaralingam P; Weltman M
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1659. PubMed ID: 25154441
    [No Abstract]   [Full Text] [Related]  

  • 19. Facing Crohn's: A Rare Association.
    Gausman V; McNeill MB; Balzora S
    Gastroenterology; 2020 Mar; 158(4):829-830. PubMed ID: 31843586
    [No Abstract]   [Full Text] [Related]  

  • 20. Recalcitrant pyoderma gangrenosum treated with thalidomide.
    Federman GL; Federman DG
    Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.